Research & Development



  “其實不止一點。”   台詞的部分他已經揣摩的差不多了,各項準備做得十分充足,為了以防萬一,陸昔年在林徵羽那要來了他哥的微信。天天啪一啪   Lin神家的小年糕︰媽媽,我搞到真的cp了!!!原本就是兩個人的粉絲,之前暗搓搓的萌真人來著,總覺得兩人蜜汁有cp感,我的直覺果然沒錯!!!天天啪影院   據說,人類有一種叫做盲從性的病,也就是別人的行為或者思維會影響到另外一群人。   說完話,就跟著老虎走出了石屋。天天啪在线视频   第□□應︰請繼續恩愛下去,多多抽獎,最好每一個紀念日都來一次。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo